15 May 2018
LexaGene announces that its prototype for more effective pathogen detection is now generating data, and is capable of identifying E. coli and Staph.
04 April 2018
LexaGene has entered into a collaboration with Ethos Veterinary Health to begin testing canine dog urine samples on LexaGene’s LX6 prototype.
22 February 2018
LexaGene honored as a Top 50-Ranked TSX Venture company, ranked by share price, trading volume and market capitalization.